AMERICAN INTERNATIONAL GROUP, INC. - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 83 filers reported holding BIOXCEL THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$25,616
-58.3%
10,125
+9.7%
0.00%
Q2 2023$61,492
-64.3%
9,233
+0.0%
0.00%
-100.0%
Q1 2023$172,232
-11.4%
9,230
+2.0%
0.00%0.0%
Q4 2022$194,308
+81.6%
9,046
-0.4%
0.00%0.0%
Q3 2022$107,000
-9.3%
9,079
+1.4%
0.00%0.0%
Q2 2022$118,000
-34.1%
8,951
+4.6%
0.00%0.0%
Q1 2022$179,000
-3.8%
8,561
-6.6%
0.00%0.0%
Q4 2021$186,000
-35.0%
9,163
-2.9%
0.00%
-50.0%
Q3 2021$286,000
+14.9%
9,437
+10.2%
0.00%
+100.0%
Q2 2021$249,000
-22.4%
8,564
+15.0%
0.00%0.0%
Q1 2021$321,000
-6.4%
7,448
+0.3%
0.00%0.0%
Q4 2020$343,000
+12.8%
7,429
+6.0%
0.00%0.0%
Q3 2020$304,000
-11.4%
7,010
+8.3%
0.00%
-50.0%
Q2 2020$343,000
+272.8%
6,473
+57.5%
0.00%
+100.0%
Q1 2020$92,000
+46.0%
4,109
-5.5%
0.00%
Q4 2019$63,000
+133.3%
4,346
+14.2%
0.00%
Q3 2019$27,000
-35.7%
3,807
-0.7%
0.00%
Q2 2019$42,0003,8330.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders